Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Oppenheimer Maintains Outperform on Albemarle, Raises Price Target to $497

Oppenheimer Maintains Outperform on Albemarle, Raises Price Target to $497

Oppenheimer analyst Colin Rusch maintains Albemarle (NYSE:ALB) with a Outperform and raises the price target from $461 to $497.

January 25, 2023

1 minute read

Oppenheimer analyst Colin Rusch maintains Albemarle (NYSE:ALB) with a Outperform and raises the price target from $461 to $497.

Where Akamai Technologies Stands With Analysts

July 22, 12:15 PM

Analysts have provided the following ratings for Akamai Technologies (NASDAQ:AKAM) within the last quarter:

July 20, 10:20 AM

JP Morgan analyst Mark Strouse maintains Array Technologies (NASDAQ:ARRY) with a Overweight and raises the price target from $26 to $28.

February 13, 5:31 AM

Keybanc analyst Josh Beck maintains Toast (NYSE:TOST) with a Overweight and raises the price target from $26 to $30.

November 2, 4:17 PM

Analysts have provided the following ratings for Intercept Pharmaceuticals (NASDAQ:ICPT) within the last quarter: